Although in a recent GWAS of T1D IL32 SNPs were not identified as significantly contributing to overall T1D risk (49), the effects of specific SNPs on age of development, endotype or response to immunotherapies have not been specifically investigated nor have IL-32 levels in the serum been studied in T1D. This evidence concerns the gene IL32 and type 1 diabetes mellitus.